GlassScriptPhysician profile
Steven A Visnaw
NPI 1801885611
$3,356.24
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $927 · 2021: $907 · 2022: $429 · 2023: $292 · 2024: $36.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $498.01 | 2019-2023 | Da Vinci Surgical System |
| Kerecis Limited | $395.74 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $350.92 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $237.54 | 2019-2023 | Exparel |
| Integra Lifesciences Corporation | $229.41 | 2020-2021 | |
| Tela Bio, INC. | $191.50 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic USA, INC. | $187.28 | 2020 | |
| Misonix INC | $142.78 | 2021 | |
| Medical Device Business Services, INC. | $123.60 | 2019 | |
| Acell, INC. | $121.73 | 2019-2020 | |
| Tei Biosciences INC | $113.52 | 2019 | |
| Portola Pharmaceuticals, LLC | $110.91 | 2020 | |
| Abbvie INC. | $88.85 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Depuy Synthes Sales INC. | $86.83 | 2020 | |
| Ethicon US, LLC | $73.53 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $61.11 | 2019-2020 | |
| Davol INC. | $52.26 | 2020-2023 | Phasix Mesh |
| Kci USA, INC. | $50.64 | 2019-2023 | V.A.C. Veraflo, Abthera Advance, Prevena |
| Takeda Pharmaceuticals U.S.A., INC. | $36.42 | 2021-2022 | |
| Innovation Technologies INC | $36.37 | 2020 | |
| Smith+Nephew, INC. | $28.01 | 2020-2023 | Renasys Go V2 Home |
| W. L. Gore & Associates, INC. | $22.69 | 2021 | |
| Aroa Biosurgery Incorporated | $20.50 | 2023 | |
| Innocoll Pharmaceuticals Limited | $20.22 | 2021 | |
| Merck Sharp & Dohme LLC | $18.30 | 2019 | |
| Medtronic, INC. | $15.32 | 2022 | |
| Shire North American Group INC | $15.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.68 | 2021 | |
| Mimedx Group, INC. | $13.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Visnaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.